Roviezzo F, Cuzzocrea S, Di Lorenzo A, Brancaleone V, Mazzon E, Di Paola R, Bucci M, Cirino G
Department of Experimental Pharmacology, University of Napoli, Federico II, Napoli, Italy.
Br J Pharmacol. 2007 Jun;151(3):377-83. doi: 10.1038/sj.bjp.0707233. Epub 2007 Apr 23.
Endothelial NO synthase (eNOS) is a dynamic enzyme tightly controlled by co- and post-translational lipid modifications, phosphorylation and regulated by protein-protein interactions. Here we have pharmacologically modulated the activation of eNOS, at different post-translational levels, to assess the role of eNOS-derived NO and of these regulatory mechanisms in intestinal injury associated with splanchnic artery occlusion (SAO) shock.
SAO shock was induced by clamping both the superior mesenteric artery and the celiac trunk for 45 min followed by 30 min of reperfusion. During ischemia, 15 min prior to reperfusion, mice were given geldanamycin, an inhibitor of hsp90 recruitment to eNOS, or LY-294002 an inhibitor of phosphatidylinositol 3-kinase (PI3K), an enzyme that initiates Akt-catalysed phosphorylation of eNOS on Ser1179. After 30 min of reperfusion, samples of ileum were taken for histological examination or for biochemical studies.
Either LY-294002 or geldanamycin reversed the increased activation of eNOS and Akt observed following SAO shock. These molecular effects were mirrored in vivo by an exacerbation of the intestinal damage. Histological damage also correlated with neutrophil infiltration, assessed as myeloperoxidase activity, and with an increased expression of the adhesion proteins: ICAM-I, VCAM, P-selectin and E-selectin.
Overall these results suggest that activation of the Akt pathway in ischemic regions of reperfused ileum is a protective event, triggered in order to protect the intestinal tissue from damage induced by ischaemia/reperfusion through a fine tuning of the endothelial NO pathway.
内皮型一氧化氮合酶(eNOS)是一种动态酶,受翻译前及翻译后脂质修饰、磷酸化的严格调控,并通过蛋白质-蛋白质相互作用进行调节。在此,我们在不同翻译后水平对eNOS的激活进行了药理学调节,以评估eNOS衍生的一氧化氮以及这些调节机制在与内脏动脉闭塞(SAO)性休克相关的肠损伤中的作用。
通过夹闭肠系膜上动脉和腹腔干45分钟,随后再灌注30分钟诱导SAO性休克。在缺血期间,再灌注前15分钟,给小鼠注射格尔德霉素(一种hsp90与eNOS结合的抑制剂)或LY-294002(一种磷脂酰肌醇3激酶(PI3K)抑制剂,PI3K是一种启动Akt催化的eNOS丝氨酸1179位点磷酸化的酶)。再灌注30分钟后,取回肠样本进行组织学检查或生化研究。
LY-294002或格尔德霉素均可逆转SAO性休克后观察到的eNOS和Akt激活增加。这些分子效应在体内表现为肠道损伤加剧。组织学损伤还与中性粒细胞浸润(以髓过氧化物酶活性评估)以及黏附蛋白ICAM-1、VCAM、P-选择素和E-选择素表达增加相关。
总体而言,这些结果表明,再灌注回肠缺血区域中Akt途径的激活是一种保护性事件,其触发是为了通过微调内皮型一氧化氮途径保护肠道组织免受缺血/再灌注诱导的损伤。